Related references
Note: Only part of the references are listed.High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from China
Yan Xie et al.
ANNALS OF HEMATOLOGY (2020)
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades
Liu Weiping et al.
CANCER MEDICINE (2020)
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
Xin Liu et al.
JAMA NETWORK OPEN (2019)
Conditional relative survival among long-term survivors of adolescent and young adult cancers
Chelsea Anderson et al.
CANCER (2018)
Hodgkin Lymphoma Version 1.2017
Richard T. Hoppe et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016
Mohsen Naghavi et al.
LANCET (2017)
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
Matthew J. Maurer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues
Mario Cazzola
BLOOD (2016)
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia
Greg Hapgood et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial
Patrice Carde et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy
Jin Won Lee et al.
BMC CANCER (2015)
Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative
Yuhree Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Getting More Out of Survival Data by Using the Hazard Function
Kenneth R. Hess et al.
CLINICAL CANCER RESEARCH (2014)
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Matthew J. Maurer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Dynamic Prognostication Using Conditional Survival Estimates
Emily C. Zabor et al.
CANCER (2013)
Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
Bastian von Tresckow et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
Simonetta Viviani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
Hans Theodor Eich et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Conditional survival in gastric cancer: a SEER database analysis
Samuel J. Wang et al.
GASTRIC CANCER (2007)
Conditional survival of patients with diffuse large B-cell lymphoma
MB Moller et al.
CANCER (2006)
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
A Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
